Microbot Medical Inc.

NASDAQ: MBOT · Real-Time Price · USD
3.13
0.09 (2.96%)
At close: Aug 14, 2025, 3:59 PM
3.12
-0.32%
Pre-market: Aug 15, 2025, 07:19 AM EDT

Microbot Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
91K 106K 102K 76K
Gross Profit
-91K -106K -102K -76K
Operating Income
-11.63M -9.86M -13.28M -11.36M
Interest Income
182K 228K 54K 44.00
Pretax Income
-11.44M -10.74M -13.17M -11.31M
Net Income
-11.44M -10.74M -13.17M -11.31M
Selling & General & Admin
5M 4.13M 5.77M 5.41M
Research & Development
6.63M 5.72M 7.74M 6.15M
Other Expenses
-91K -106K -224K -206K
Operating Expenses
11.53M 9.75M 13.28M 11.36M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a 213K 224K 206K
Cost & Expenses
11.63M 9.86M 13.28M 11.36M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
15.64M 10.2M 7.26M 7.11M
Shares Outstanding (Diluted)
15.64M 10.2M 7.26M 7.11M
EPS (Basic)
-0.73 -1.05 -1.81 -1.59
EPS (Diluted)
-0.73 -1.05 -1.81 -1.59
EBITDA
-11.35M -10.63M -13.24M -11.32M
EBIT
-11.44M -10.74M -13.28M -11.36M
Depreciation & Amortization
91K 106K 102K 76K